Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2020 Results and Corporate Update

Rhea-AI Summary

Editas Medicine will host a conference call and webcast on February 25, 2021, at 8:00 a.m. ET to discuss a corporate update and its fourth quarter and full year 2020 results. Investors can join through the US toll-free number (844) 348-3801 or internationally at (213) 358-0955, using Conference ID 7172199. The webcast will also be available on Editas Medicine's website.

Editas is focused on genome editing technologies, including CRISPR, aimed at developing treatments for serious genetic diseases.

CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Thursday, February 25, 2021, at 8:00 a.m. ET to discuss a corporate update and results for the fourth quarter and full year of 2020.

Conference Call & Webcast Details
Date:	Thursday, February 25, 2021
Time:	8:00 am Eastern Time
Toll Free:	(844) 348-3801
International:	(213) 358-0955
Conference ID:	7172199
Webcast:	https://edge.media-server.com/mmc/p/hg6sbc5q

A live webcast of the conference call can be accessed in the Investors section of Editas Medicine website at https://www.editasmedicine.com/.

About Editas Medicine
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.

Contacts:
Media
Cristi Barnett
(617) 401-0113
cristi.barnett@editasmed.com

Investors
Editas Medicine Investor Relations
(617) 401-9052
ir@editasmed.com

FAQ

When is the Editas Medicine conference call scheduled?

The Editas Medicine conference call is scheduled for February 25, 2021, at 8:00 a.m. ET.

What will be discussed during the Editas Medicine conference call?

The conference call will cover a corporate update and results for the fourth quarter and full year of 2020.

How can I access the Editas Medicine conference call?

You can access the conference call by calling (844) 348-3801 for US or (213) 358-0955 for international participants.

What is the conference ID for the Editas Medicine call?

The conference ID for the Editas Medicine call is 7172199.

Is there a webcast available for the Editas Medicine conference call?

Yes, a live webcast of the conference call can be accessed on Editas Medicine's website.

What is the focus of Editas Medicine?

Editas Medicine focuses on genome editing using CRISPR technology to develop treatments for serious diseases.